“Clinical trial of 20% Mat lippia (bucan) topical ointment for cutaneous leishmaniasis; a preliminary trial”, J Pak Assoc Dermatol, vol. 15, no. 2, pp. 108–112, Dec. 2016, doi: 10.66344/jpad.15.2.2005.627.